Cencora has appointed Ellen Cooper, Chairman, President and CEO of Lincoln Financial, as an independent director effective January 20, 2026. Cooper brings over 30 years of leadership in regulated financial services, most recently serving as Executive Vice President and CIO at Lincoln before becoming CEO in May 2022. Her prior roles include Global Head of Insurance Strategy at Goldman Sachs Asset Management and Chief Risk Officer for AEGON Americas. Cencora’s Board Chair Mark Durcan noted that Cooper’s risk-management acumen and strategic insight will enhance oversight of the company’s long-term growth initiatives. Cooper holds a BBA from Temple University and designations as a Fellow of the Society of Actuaries, Chartered Enterprise Risk Analyst, and CFA charter holder.

On January 23, 2026, Cencora announced a multi-year collaboration with Curant Rare aimed at streamlining market access for rare and orphan therapies. The partnership combines Cencora’s global pharmaceutical logistics platform—with capabilities across storage, distribution, pharmacovigilance and market access support—with Curant Rare’s specialty pharmacy services and patient engagement solutions. Together, they will offer pharmaceutical sponsors a unified commercialization model designed to reduce time-to-therapy and improve patient adherence in ultra-rare disease segments. Cencora, ranked #10 on the Fortune 500 with over $300 billion in annual revenue and a 51,000-strong workforce, projects the initiative will support over 50 pipeline programs within two years, addressing regulatory complexities across North America and Europe.